Safety updates
A safety update gives practical information on the safety of health products and emerging safety issues. These updates are provided for health professionals.
The safety updates replaced the Australian Adverse Drug Reactions Bulletin in 2010.
Find archived copies 1995 to 2009 at the National Library of Australia in Trove Australian Adverse Drug Reactions Bulletin archive
Search the Article index from 1982 to 2009
Medicine safety updates
Medicines Safety Update (MSU) provides health professionals with practical information and advice on drug safety and information about emerging safety issues.
The articles also provide information on adverse event reporting and how health professionals can contribute to safety monitoring in Australia.
Safety update articles are published as relevant topics arise.
Health professionals and interested persons can subscribe and receive email notifications when new articles are published.
Medical devices safety updates
Medical Devices Safety Update (MDSU) provides health professionals with practical information and advice on medical device safety and information about emerging safety issues.
The articles provide information on adverse event reporting and how health professionals can contribute to safety monitoring in Australia.
Safety update articles are published as relevant topics arise.
Health professionals and interested persons can subscribe and receive email notifications when new articles are published.
Latest Safety updates
-
Medicines Safety Update - Information for health professionals
-
Oral preparations containing more than 50 mg but not more than 200 mg per recommended daily dose of vitamin B6 will be rescheduled as Pharmacist Only Medicines from 1 June 2027.
-
Information for health professionals about medicines with safety related updates to their Product Information.
-
Information for health professionals about medicines with safety related updates to their Product Information.
-
Information for health professionals about medicines with safety related updates to their Product Information.
-
Our investigation into the potential for reduced effectiveness of oral contraception during initiation or dose escalations with Mounjaro (tirzepatide) has found that this association could not be ruled out.